Is Cimzia (certolizumab pegol) considered safe in pregnancy?
Cimzia is a TNF-alpha inhibitor (certolizumab pegol). Based on available clinical experience and guidance for biologic TNF blockers, Cimzia is generally considered an option during pregnancy when treatment is needed, especially if you were already taking it before becoming pregnant or it’s the best treatment for controlling inflammatory disease. Use in pregnancy is typically framed around benefits to the mother (disease control) versus any fetal risks.
What do experts say about timing in pregnancy (first vs later trimesters)?
For TNF inhibitors, most safety discussions focus on overall exposure and on the fact that stopping effective therapy can allow maternal disease to flare, which itself can increase pregnancy risks. Cimzia is commonly treated as one of the lower-transfer options among biologics because certolizumab pegol has a different structure than many other anti-TNF drugs (it lacks an Fc region), which affects how much crosses the placenta. That placental-transfer factor is one reason clinicians often prefer Cimzia when a TNF inhibitor is needed in pregnancy.
Will Cimzia affect the baby after birth or with breastfeeding?
The main patient concern after delivery is whether continuing treatment increases infection risk for the newborn, since immune-modulating drugs can persist for a time after birth depending on exposure timing. Clinicians often coordinate with pediatrics on newborn monitoring and vaccination planning if biologics were used during later pregnancy.
Breastfeeding guidance is usually individualized, but TNF inhibitors like Cimzia are commonly considered compatible with breastfeeding in practice because infant exposure through breast milk is expected to be low.
What risks should patients discuss with their OB-GYN or rheumatologist?
Pregnancy risk discussions for Cimzia usually cover:
- How active your underlying condition is (rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, etc.), since uncontrolled disease can harm both parent and pregnancy.
- Whether you should continue Cimzia through certain gestational windows versus pause (if your disease is stable).
- Infection risk for you during pregnancy and how to watch for symptoms.
- Newborn planning if you used biologics in later pregnancy (including whether the baby should delay certain live vaccines).
Is Cimzia safer than other anti-TNF drugs during pregnancy?
Among anti-TNF therapies, Cimzia is often viewed as comparatively favorable in pregnancy because certolizumab pegol has reduced placental transfer compared with other anti-TNF monoclonal antibodies. That said, the “safety” difference is still about balancing maternal disease control and exposure risk, and the best choice depends on your diagnosis and treatment history.
What if you’re already pregnant and on Cimzia?
If you are already taking Cimzia, the usual approach is not to stop it suddenly without your care team. Your OB-GYN and the prescribing specialist typically weigh whether continuing helps prevent a flare versus the timing of any last doses before delivery.
If you tell me what condition you’re treating (e.g., Crohn’s, rheumatoid arthritis, psoriatic arthritis) and which trimester you’re in, I can tailor the practical safety considerations and common counseling points.